Impact of the addition of bevacizumab, oxaliplatin, or irinotecan to fluoropyrimidin in the first-line treatment of metastatic colorectal cancer in elderly patients
暂无分享,去创建一个
L. Zelek | E. Maillard | T. Aparicio | G. D. Guetz | T. Landre | C. Taleb | D. Ghebriou | G. Guetz